
|Videos|February 2, 2021
Clinical care pathway demonstrates efficacy for patients with overactive bladder
Author(s)Urology Times staff
Chris Du, MD, discusses findings from a study published in Neurourology and Urodynamics.
Advertisement
In this interview, Chris Du, MD, discusses findings from the Neurourology and Urodynamics paper, A retrospective longitudinal evaluation of new overactive bladder patients in an FPMRS urologist practice: Are patients following up and utilizing third‐line therapies?, for which he served as a study author. Du is a urology resident at Stony Brook University, Stony Brook, New York.
More videos:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Perioperative Treatment for High-Risk Localized Prostate Cancer, With Keyan Salari, MD, PhD
2
Ac-225 rosopatamab tetraxetan shows promising activity in Lu-PSMA–pretreated mCRPC
3
Sanoj Punnen, MD, on balancing ADT efficacy with cardiovascular safety
4
Evolving Systemic Therapies in mCSPC
5













